Skip to content
Abate As Industries logo

Abate As Industries

531658 BSE
Price unavailable

Abate As Industries (ABATEAS) share price was ₹7.19 at the 28 Oct 2026 close; market capitalisation ₹113 Cr; P/E (TTM) 9.22; sector Healthcare Services. The share price fell 57.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 44.4% year on year to ₹22.82 Cr and net profit fell 0.4% year on year to ₹2.24 Cr (compared with Jun 2025). Promoters held 32.42% of Abate As Industries in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 59/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹7.19 −8.96 −55.48% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹113 Cr
P/E (TTM)
9.22
EBITDA
₹15.30 Cr
Return on Equity
6.01%
Debt to Equity
0.06
Book Value
₹11.00
EPS (TTM)
₹0.78
52W High
₹20.11
52W Low
₹6.16

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

₹8,149.5056.081,17,177 Cr12.360.26%20.08%19.79%26,675 Cr2,171 Cr
₹638.8085.1784,026 Cr5.110.00%10.42%9.50%11,400 Cr906 Cr
₹859.3057.3683,637 Cr7.780.24%13.42%12.70%8,879 Cr1,457 Cr
₹677.15110.1159,025 Cr14.030.45%8.84%9.71%5,006 Cr363 Cr
₹756.4554.5057,109 Cr5.770.14%10.47%12.13%9,607 Cr1,070 Cr
₹1,300.1062.8434,956 Cr8.820.04%13.91%15.05%4,800 Cr552 Cr
₹1,708.4042.7734,913 Cr7.690.26%17.85%11.39%9,185 Cr816 Cr
Abate As Industries (this company)
—9.22113 Cr0.650.00%6.01%6.57%144 Cr12 Cr
Median 8 companies₹859.3056.7258,067 Cr7.740.19%11.95%11.76%9,032 Cr861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

59 Good
Overall score

Data confidence 95/100

Category scores

Quality Strong 67
Returns, margins, earnings quality 22% weight
Valuation Strong 72
Cheap vs sector & own history 24% weight
Growth Strong 99
Sales & profit trajectory 9% weight
Financial Health Good 63
Solvency, leverage, coverage 9% weight
Momentum Poor 11
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company is almost debt free.
  • Stock is trading at 0.69 times its book value
  • Debtor days have improved from 245 to 59.2 days.
  • Company's working capital requirements have reduced from 357 days to 75.1 days

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 32.4%

Technical Indicators

Oscillators

Bearish

Bearish
3
Neutral
5
Bullish
1

Overall

Bearish

Bearish
13
Neutral
5
Bullish
1

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
971%

change over 1 year

Net Income Growth
991%

change over 1 year

Cash Flow Change
963%

change over 1 year

EBITDA Margin Change
-16.58%

change over 1 year Operating margin 14.64% · Jun 2026

Quarterly Results

Particulars Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
14.09
41.06
42.13
42.69
33.94
22.82
Expenses
0.04
0.03
0.02
13.28
38.56
38.28
38.76
30.84
19.48
Operating Profit
-0.04
-0.03
-0.02
0.81
2.5
3.85
3.93
3.1
3.34
OPM %
—
—
—
5.75%
6.09%
9.14%
9.21%
9.13%
14.64%
Other Income
0
0
0
0.97
0.51
1.13
0.06
0.53
0.27
Interest
0
0
0
0.06
0.11
0.17
0.15
0.13
0.14
Depreciation
0
0
0
0.55
0.49
0.52
0.52
0.52
0.74
PBT
-0.04
-0.03
-0.02
1.17
2.41
4.29
3.32
2.98
2.73
Tax %
0%
0%
0%
-1.71%
6.64%
5.13%
8.43%
2.01%
17.95%
Net Profit
-0.04
-0.03
-0.02
1.19
2.25
4.07
3.06
2.93
2.24
EPS (₹)
-0.04
-0.03
-0.02
0.08
0.14
0.26
0.19
0.19
0.14
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2025Mar 2026TTM
Sales
14
159
142
Expenses
13
146
127
Operating Profit
1
13
14
OPM %
5%
8%
10%
Other Income
1
2
2
Interest
0
1
1
Depreciation
1
2
2
PBT
1
13
13
Tax %
-2%
6%
—
Net Profit
1
12
12
EPS (₹)
0.05
0.55
0.78
Div. Payout %
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2025Mar 2026
Equity Capital
79
158
Reserves
85
16
Borrowings
11
10
Other Liabilities
31
40
Total Liabilities
206
223
Fixed Assets
149
150
CWIP
0
0
Investments
14
14
Other Assets
43
59
Total Assets
206
223
Figures in ₹ Crores

Cash Flow

Particulars Mar 2025Mar 2026
Operating
-1
6
Investing
-162
-2
Financing
165
-2
Net Cash Flow
2
2
Free Cash Flow
-1
3
CFO/OP
-91
56
Figures in ₹ Crores

Ratios

Particulars Mar 2025Mar 2026
Debtor Days
430
59
Inventory Days
413
49
Days Payable
209
36
Cash Conversion Cycle
635
72
Working Capital Days
640
75
ROCE %
—
7%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Abate As Industries insights

62 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Others52.89%Public14.69%Promot.32.42%As ofSep 2026

Documents

Frequently Asked Questions about Abate As Industries

What does Abate As Industries Ltd do?
Incorporated in 1991, Abate As Industries Ltd primarily operates in the eye healthcare segment through its super specialty hospitals and optical outlets[1]
Where is Abate As Industries Ltd (ABATEAS) listed?
Abate As Industries Ltd trades under code 531658 on the BSE.
Which sector does Abate As Industries Ltd belong to?
Abate As Industries Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of Abate As Industries Ltd?
Abate As Industries Ltd has a market capitalisation of ₹113.31 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Abate As Industries Ltd?
Abate As Industries Ltd trades at a PE ratio of 9.22 as of 28 Oct 2026, on earnings per share of ₹0.78, against a book value of ₹11 per share.
What is the 52-week high and low of Abate As Industries Ltd?
Over the last 52 weeks Abate As Industries Ltd has traded between ₹6.16 and ₹20.11 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Abate As Industries Ltd?
Abate As Industries Ltd reported a return on equity of 6.01%. Its debt-to-equity ratio is 0.06.

Company Information

Incorporated in 1991, Abate As Industries Ltd primarily operates in the eye healthcare segment through its super specialty hospitals and optical outlets[1]

Website abateas.com
CEO Ms. Heena Kausar Mohd Amin Rangari
Listed 1996-05-08
Face Value ₹ 10
Shares Outstanding 15,75,93,985

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531658.md for Abate As Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More